Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Huamao Ye is a pioneering urologic surgeon and researcher whose work has fundamentally advanced the surgical management of kidney cancer, particularly through the adoption and refinement of robotic-assisted techniques. His primary research areas center on minimally invasive nephron-sparing surgery, comparative effectiveness of robotic versus open and laparoscopic approaches, and the oncologic outcomes of robotic nephroureterectomy. Dr. Ye’s major contributions include leading one of the first comprehensive meta-analyses comparing robotic partial nephrectomy (RPN) to open partial nephrectomy (OPN), which demonstrated RPN’s advantages in reducing blood loss and hospital stay while preserving renal function—a study that has garnered 148 citations and become a cornerstone in the field. He further validated these findings through propensity-score matched analyses, showing superior perioperative outcomes for RPN over both laparoscopic and open approaches. Notably, Dr. Ye also described a novel single-docking technique for robotic-assisted nephroureterectomy, eliminating the need for intraoperative repositioning, and reported its long-term oncologic outcomes. His work has been instrumental in establishing robotic surgery as a safe, effective standard for complex kidney tumors, and his studies are widely referenced by surgeons and researchers seeking evidence-based guidance on surgical decision-making.